Myrna Fisher

The AKT kinase is activated in multiple myeloma tumor cells

Jung-Hsin Hsu, Yijiang Shi, Stanisław Krajewski et al. · Blood · 2001 · 199 citations · Full text

Medicine, Cancer Biology, Oncology +13

Mechanism by Which Mammalian Target of Rapamycin Inhibitors Sensitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis

Huajun Yan, Patrick Frost, Yijiang Shi et al. · Cancer Research · 2006 · 108 citations

Life Sciences, Oncology, Pharmacology +17

Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas

Jiabin An, Y. Sun, Myrna Fisher et al. · Leukemia · 2004 · 89 citations

Medicine, Oncology, Pharmacology +14

Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses

Jung-Hsin Hsu, Yijiang Shi, Liping Hu et al. · Oncogene · 2002 · 87 citations

Medicine, Cancer Biology, Oncology +16

Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent.

Jiabin An, Yiping Sun, Myrna Fisher et al. · PubMed · 2004 · 64 citations

Medicine, Oncology, Pharmacology +17